Vaccine production first requires candidate vaccine viruses and reagents, which face hurdles from the UN Nagoya Protocol and initiatives. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
